Peripheral Interventions Market Demonstrates Long-Term Growth Potential At 8.8% CAGR

The peripheral interventions market is positioned for significant advancement as medical technology and treatment preferences evolve. With a rising inclination toward less invasive procedures and continuous innovation, this sector is set to witness substantial growth over the coming years. Let's explore the market's size projections, key drivers, major players, trends, and segmentation to understand its future trajectory.

Projected Market Size and Growth in Peripheral Interventions
The peripheral interventions market is expected to experience robust growth, reaching a valuation of $15.28 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 8.8%. Factors contributing to this rise include the increasing preference for minimally invasive treatment options, breakthroughs in stent and guide wire technology, growth in ambulatory surgical centers, heightened healthcare spending in emerging economies, and a stronger demand for procedures that offer quicker recovery times. Key trends anticipated to influence this market include a shift toward minimally invasive peripheral procedures, broader adoption of drug-eluting and covered stents, increased utilization of image-guided endovascular interventions, growing demand for atherectomy and thrombectomy devices, and the expansion of outpatient peripheral intervention settings.

Download a free sample of the Peripheral Interventions market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25871&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Prominent Companies Leading the Peripheral Interventions Market
Several leading players dominate the peripheral interventions landscape, including Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Johnson & Johnson, Terumo Corporation, B. Braun Melsungen AG, Nipro Corporation, Teleflex Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., Lepu Medical Technology Beijing Co. Ltd., Cordis Corporation, MicroPort Scientific Corporation, Penumbra Inc., W. L. Gore & Associates Inc., Reflow Medical Inc., ArtVentive Medical Group Inc., AngioDynamics Inc., Cook Medical Inc., BD Bard Peripheral Vascular Inc., Endologix Inc., Cardiovascular Systems Inc., and Surmodics Inc.

Significant Acquisition Expanding Teleflex's Reach
In July 2025, Teleflex Incorporated, a US-based medical technology firm, purchased the vascular intervention business of Germany's Biotronik SE & Co. KG for $892 million. This deal is aimed at broadening Teleflex's global footprint in the peripheral interventions arena, enhancing its portfolio in interventional cardiology, and leveraging Biotronik's established vascular intervention products to boost research, development, and long-term growth. Biotronik is known for its solutions catering to coronary as well as peripheral vascular interventions.

View the full Peripheral Interventions market report:
https://www.thebusinessresearchcompany.com/report/peripheral-interventions-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Innovative Trends Shaping the Peripheral Interventions Market
Industry leaders are focusing on pioneering new devices to improve the treatment of calcified peripheral artery disease, such as peripheral intravascular lithotripsy (IVL) catheters. These devices utilize sonic pressure waves to break down calcified plaques in peripheral arteries, facilitating safer and more effective angioplasty or stent placement. For example, in March 2025, Shockwave Medical Inc., based in the US, introduced the Shockwave Javelin Peripheral IVL Catheter. This device features a 150 cm working length and a single distal emitter delivering up to 120 shockwave pulses, creating a spherical energy field that modifies calcium deposits. This innovation enables the catheter to navigate extremely narrowed or blocked vessels that other devices struggle to cross. Clinical trials have shown the Javelin catheter to be as safe and effective as existing balloon-based IVL catheters, offering a transformative solution for managing complex calcified peripheral lesions and enhancing procedural success for patients with peripheral artery disease.

Detailed Breakdown of Market Segments Driving Growth
This report categorizes the peripheral interventions market into several important segments:

1) Product Types: Catheters, Sheaths, Stents, Guide Wires, Atherectomy Devices, Embolic Devices, Thrombectomy Devices, Inferior Vena Cava (IVC) Filters, and Other Types
2) Technology: Drug-Eluting Stents, Balloon-Expandable Stents, Self-Expanding Stents, Rotational Atherectomy, Directional Atherectomy
3) Applications: Peripheral Artery Disease, Venous Thromboembolism, Other Applications
4) End Users: Hospitals, Ambulatory Surgical Centers, Clinics, Specialty Vascular Centers

Further subsegments include:
- Catheters divided into Angiographic, Balloon, Guiding, and Support types
- Sheaths split into Introducer and Guiding Sheaths
- Stents categorized as Bare Metal, Drug-Eluting, Covered, Self-Expanding, and Balloon-Expandable
- Guide Wires classified by Hydrophilic, Nitinol, and Stainless Steel materials
- Atherectomy Devices grouped into Directional, Rotational, Orbital, and Laser
- Embolic Devices including Embolization Coils, Embolic Protection Devices, and Liquid Embolic Agents
- Thrombectomy Devices covering Mechanical, Aspiration, and Rheolytic types
- IVC Filters divided into Permanent and Retrievable
- Other Types including Vascular Closure Devices, Hemostatic Agents, and Guide Catheters

This comprehensive segmentation offers a clear view of the components fueling the peripheral interventions market's ongoing expansion and innovation.

Our 2026 reports feature deeper market intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.